Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novavax COVID-19 vaccine plus adjuvant study in South African adults
PACTR202009726132275Phase 2Completed
- Sponsor
- Novavax
- Start
- Jul 2020
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of NVX-CoV2373 and Matrix M in coronavirus disease 2019 (COVID-19), sponsored by Novavax. Started Jul 2020; status: completed.
02
Drugs
NVX-CoV2373Matrix M
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202009726132275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202009726132275.